- Home
- UGRO vs BFRI Comparison
UGRO vs BFRI Comparison
Compare UGRO & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGRO
- BFRI
- Stock Information
- Founded
- UGRO 2014
- BFRI 1997
- Country
- UGRO United States
- BFRI United States
- Employees
- UGRO N/A
- BFRI N/A
- Industry
- UGRO Industrial Specialties
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- UGRO Consumer Discretionary
- BFRI Health Care
- Exchange
- UGRO Nasdaq
- BFRI Nasdaq
- Market Cap
- UGRO 8.8M
- BFRI 8.7M
- IPO Year
- UGRO N/A
- BFRI 2021
- Fundamental
- Price
- UGRO $0.45
- BFRI $0.81
- Analyst Decision
- UGRO Strong Buy
- BFRI Strong Buy
- Analyst Count
- UGRO 2
- BFRI 1
- Target Price
- UGRO $3.13
- BFRI $7.00
- AVG Volume (30 Days)
- UGRO 101.1K
- BFRI 94.9K
- Earning Date
- UGRO 04-29-2025
- BFRI 03-21-2025
- Dividend Yield
- UGRO N/A
- BFRI N/A
- EPS Growth
- UGRO N/A
- BFRI N/A
- EPS
- UGRO N/A
- BFRI N/A
- Revenue
- UGRO $59,985,133.00
- BFRI $37,321,000.00
- Revenue This Year
- UGRO $2.17
- BFRI $28.62
- Revenue Next Year
- UGRO $27.19
- BFRI $27.07
- P/E Ratio
- UGRO N/A
- BFRI N/A
- Revenue Growth
- UGRO N/A
- BFRI 9.54
- 52 Week Low
- UGRO $0.38
- BFRI $0.65
- 52 Week High
- UGRO $2.16
- BFRI $2.43
- Technical
- Relative Strength Index (RSI)
- UGRO 17.79
- BFRI 35.78
- Support Level
- UGRO $0.45
- BFRI $0.81
- Resistance Level
- UGRO $0.62
- BFRI $0.96
- Average True Range (ATR)
- UGRO 0.07
- BFRI 0.09
- MACD
- UGRO -0.03
- BFRI -0.01
- Stochastic Oscillator
- UGRO 15.39
- BFRI 4.33
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.